Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.HIV Medicine|January 7, 2021
Acquired immune deficiency syndrome (AIDS) and late presentation in Poland - data from Test and Keep in Care (TAK) Polska projectE Jabłonowska, B Szetela, M Bielecki, et al.AIDS (London, England)|December 12, 2001
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapineF W Wit, R Wood, A Horban, et al.Journal of Viral Hepatitis|November 22, 2014
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trialM Buti, R Flisiak, J-H Kao, et al.Journal of Neurovirology|October 10, 2018
Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatmentNatalia Gawron, M Choiński, B Szymańska-Kotwica, et al.HIV Medicine|October 23, 2015
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome StatementsC Mussini, A Antinori, S Bhagani, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 16, 2020
HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe?J D Kowalska, A Skrzat-Klapaczyńska, D Bursa, et al.HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.HIV Medicine|February 24, 2006
Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wastingJ Gold, M J Batterham, H Rekers, et al.HIV Medicine|October 6, 2020
Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network GroupT Balayan, J Begovac, A Skrzat-Klapaczyńska, et al.Pageof 5